LexDanaLexDanabeta
Inventor

Steven MCKERRALL

Inventor
US

Overview

3→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes22%
C07CAcyclic or carbocyclic compounds11%
PatentTitleYear
12,209,075Pyridine-sulfonamide derivatives as sodium channel inhibitors202512,139,496Therapeutic compounds and methods of use thereof202411,203,572Substituted benzamides and methods of use thereof2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2025Patents assigned to GENENTECH INC (3)· patent assignee history
2021Patents assigned to XENON PHARMACEUTICALS INC (1)· patent assignee history
2021–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENENTECH INC32021–2025
XENON PHARMACEUTICALS INC12021
Locations
LocationPatentsSpan
US32021–2025